Harrow Selling And Marketing Expenses vs Total Revenue Analysis

HROW Stock

USD 42.90 0.98 2.23%

Harrow Health financial indicator trend analysis is much more than just examining Harrow Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Harrow Health is a good investment. Please check the relationship between Harrow Health Selling And Marketing Expenses and its Total Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.

Selling And Marketing Expenses vs Total Revenue

Selling And Marketing Expenses vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Harrow Health Selling And Marketing Expenses account and Total Revenue. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Harrow Health's Selling And Marketing Expenses and Total Revenue is 0.89. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Harrow Health, assuming nothing else is changed. The correlation between historical values of Harrow Health's Selling And Marketing Expenses and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of Harrow Health are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Selling And Marketing Expenses i.e., Harrow Health's Selling And Marketing Expenses and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.89

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Selling And Marketing Expenses

Total Revenue

Total revenue comprises all receipts Harrow Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Harrow Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Harrow Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.At this time, Harrow Health's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to climb to about 736 K in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.73 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	54.3M	63.2M	90.6M	95.1M
Total Revenue	72.5M	88.6M	130.2M	136.7M

Gross Profit Total Revenue

Harrow Health fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Other Current Assets	Accounts Payable	Non Current Liabilities Total	Property Plant And Equipment Net	Non Current Assets Total	Property Plant And Equipment Gross	Other Liab	Long Term Debt	Net Tangible Assets	Current Deferred Revenue	Retained Earnings Total Equity
Total Assets		0.92	0.98	0.94	0.95	-0.82	0.86	0.9	0.8	0.77	0.92	1.0	0.97	0.59	0.99	0.66	0.95	0.99	0.48	0.98	0.86	0.2	0.99	-0.13	0.27	-0.69
Other Current Liab	0.92		0.95	0.9	0.98	-0.67	0.63	0.66	0.64	0.61	0.81	0.91	0.8	0.39	0.9	0.35	0.79	0.89	0.27	0.98	0.66	0.2	0.89	-0.16	0.14	-0.5
Total Current Liabilities	0.98	0.95		0.95	0.96	-0.82	0.77	0.83	0.8	0.77	0.93	0.97	0.92	0.58	0.96	0.58	0.94	0.95	0.49	0.98	0.83	0.29	0.95	-0.08	0.34	-0.69
Total Stockholder Equity	0.94	0.9	0.95		0.89	-0.75	0.73	0.83	0.77	0.78	0.9	0.91	0.9	0.56	0.89	0.53	0.88	0.89	0.49	0.93	0.78	0.12	0.88	0.19	0.25	-0.61
Net Debt	0.95	0.98	0.96	0.89		-0.76	0.67	0.73	0.75	0.72	0.87	0.94	0.85	0.52	0.94	0.41	0.84	0.93	0.43	0.98	0.78	0.23	0.92	-0.17	0.22	-0.62
Retained Earnings	-0.82	-0.67	-0.82	-0.75	-0.76		-0.74	-0.82	-0.92	-0.94	-0.96	-0.82	-0.84	-0.83	-0.82	-0.62	-0.85	-0.81	-0.79	-0.76	-0.92	-0.52	-0.8	0.07	-0.3	0.97
Cash	0.86	0.63	0.77	0.73	0.67	-0.74		0.95	0.69	0.66	0.78	0.88	0.94	0.55	0.89	0.9	0.9	0.9	0.45	0.75	0.84	0.12	0.9	-0.26	0.26	-0.68
Cash And Short Term Investments	0.9	0.66	0.83	0.83	0.73	-0.82	0.95		0.83	0.82	0.87	0.9	0.98	0.7	0.9	0.85	0.93	0.91	0.63	0.78	0.93	0.13	0.9	-0.02	0.33	-0.77
Common Stock Total Equity	0.8	0.64	0.8	0.77	0.75	-0.92	0.69	0.83		0.94	0.92	0.79	0.83	0.9	0.79	0.58	0.82	0.78	0.82	0.73	0.93	0.36	0.77	0.09	0.4	-0.89
Common Stock Shares Outstanding	0.77	0.61	0.77	0.78	0.72	-0.94	0.66	0.82	0.94		0.93	0.76	0.82	0.85	0.75	0.54	0.8	0.75	0.85	0.7	0.92	0.33	0.73	0.2	0.27	-0.93
Other Stockholder Equity	0.92	0.81	0.93	0.9	0.87	-0.96	0.78	0.87	0.92	0.93		0.91	0.92	0.76	0.9	0.62	0.92	0.9	0.7	0.88	0.92	0.39	0.89	0.02	0.3	-0.88
Total Liab	1.0	0.91	0.97	0.91	0.94	-0.82	0.88	0.9	0.79	0.76	0.91		0.97	0.58	1.0	0.68	0.95	1.0	0.48	0.97	0.87	0.21	1.0	-0.21	0.28	-0.71
Total Current Assets	0.97	0.8	0.92	0.9	0.85	-0.84	0.94	0.98	0.83	0.82	0.92	0.97		0.66	0.97	0.79	0.97	0.97	0.58	0.89	0.92	0.17	0.97	-0.08	0.32	-0.75
Common Stock	0.59	0.39	0.58	0.56	0.52	-0.83	0.55	0.7	0.9	0.85	0.76	0.58	0.66		0.58	0.51	0.64	0.57	0.91	0.49	0.82	0.34	0.56	0.15	0.4	-0.83
Short Long Term Debt Total	0.99	0.9	0.96	0.89	0.94	-0.82	0.89	0.9	0.79	0.75	0.9	1.0	0.97	0.58		0.69	0.95	1.0	0.47	0.96	0.87	0.19	1.0	-0.23	0.26	-0.7
Other Current Assets	0.66	0.35	0.58	0.53	0.41	-0.62	0.9	0.85	0.58	0.54	0.62	0.68	0.79	0.51	0.69		0.81	0.7	0.46	0.51	0.71	0.13	0.7	-0.19	0.45	-0.62
Accounts Payable	0.95	0.79	0.94	0.88	0.84	-0.85	0.9	0.93	0.82	0.8	0.92	0.95	0.97	0.64	0.95	0.81		0.95	0.57	0.89	0.89	0.26	0.95	-0.11	0.43	-0.77
Non Current Liabilities Total	0.99	0.89	0.95	0.89	0.93	-0.81	0.9	0.91	0.78	0.75	0.9	1.0	0.97	0.57	1.0	0.7	0.95		0.47	0.96	0.87	0.19	1.0	-0.24	0.26	-0.7
Property Plant And Equipment Net	0.48	0.27	0.49	0.49	0.43	-0.79	0.45	0.63	0.82	0.85	0.7	0.48	0.58	0.91	0.47	0.46	0.57	0.47		0.38	0.81	0.4	0.44	0.26	0.4	-0.85
Non Current Assets Total	0.98	0.98	0.98	0.93	0.98	-0.76	0.75	0.78	0.73	0.7	0.88	0.97	0.89	0.49	0.96	0.51	0.89	0.96	0.38		0.77	0.21	0.96	-0.16	0.21	-0.61
Property Plant And Equipment Gross	0.86	0.66	0.83	0.78	0.78	-0.92	0.84	0.93	0.93	0.92	0.92	0.87	0.92	0.82	0.87	0.71	0.89	0.87	0.81	0.77		0.32	0.86	-0.05	0.35	-0.91
Other Liab	0.2	0.2	0.29	0.12	0.23	-0.52	0.12	0.13	0.36	0.33	0.39	0.21	0.17	0.34	0.19	0.13	0.26	0.19	0.4	0.21	0.32		0.18	-0.19	0.29	-0.52
Long Term Debt	0.99	0.89	0.95	0.88	0.92	-0.8	0.9	0.9	0.77	0.73	0.89	1.0	0.97	0.56	1.0	0.7	0.95	1.0	0.44	0.96	0.86	0.18		-0.26	0.25	-0.69
Net Tangible Assets	-0.13	-0.16	-0.08	0.19	-0.17	0.07	-0.26	-0.02	0.09	0.2	0.02	-0.21	-0.08	0.15	-0.23	-0.19	-0.11	-0.24	0.26	-0.16	-0.05	-0.19	-0.26		-0.01	0.06
Current Deferred Revenue	0.27	0.14	0.34	0.25	0.22	-0.3	0.26	0.33	0.4	0.27	0.3	0.28	0.32	0.4	0.26	0.45	0.43	0.26	0.4	0.21	0.35	0.29	0.25	-0.01		-0.34
Retained Earnings Total Equity	-0.69	-0.5	-0.69	-0.61	-0.62	0.97	-0.68	-0.77	-0.89	-0.93	-0.88	-0.71	-0.75	-0.83	-0.7	-0.62	-0.77	-0.7	-0.85	-0.61	-0.91	-0.52	-0.69	0.06	-0.34

Click cells to compare fundamentals

Harrow Health Account Relationship Matchups

Harrow Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	59.1M	57.5M	98.3M	157.0M	311.8M	327.3M
Other Current Liab	2.4M	1.7M	4.9M	(836K)	27.0M	28.4M
Total Current Liabilities	12.3M	10.8M	9.7M	18.6M	49.3M	51.8M
Total Stockholder Equity	27.7M	27.2M	11.3M	27.2M	70.4M	73.9M
Net Debt	16.2M	19.4M	35.8M	7.9M	116.4M	122.2M
Retained Earnings	(74.0M)	(77.4M)	(95.4M)	(109.5M)	(133.9M)	(127.2M)
Cash	4.7M	4.1M	42.2M	96.3M	74.1M	77.8M
Cash And Short Term Investments	29.9M	32.6M	50.7M	96.3M	82.8M	86.9M
Common Stock Shares Outstanding	26.5M	25.9M	26.8M	27.5M	32.6M	34.2M
Liabilities And Stockholders Equity	59.1M	57.5M	98.3M	157.0M	311.8M	327.3M
Other Stockholder Equity	101.7M	104.6M	106.7M	136.7M	204.2M	214.4M
Total Liab	31.7M	30.6M	87.4M	130.1M	241.8M	253.8M
Total Current Assets	36.8M	40.1M	60.7M	118.3M	139.1M	146.0M
Short Long Term Debt Total	21.0M	23.5M	78.0M	104.9M	190.5M	200.0M
Other Current Assets	786K	941K	1.3M	22.0M	9.0M	9.4M
Accounts Payable	7.4M	3.6M	5.2M	18.6M	21.4M	22.5M
Non Current Liabilities Total	19.4M	19.8M	77.7M	111.5M	192.4M	202.0M
Property Plant And Equipment Net	11.9M	11.3M	9.1M	11.0M	10.3M	5.6M
Non Current Assets Total	22.3M	17.3M	37.7M	37.2M	172.7M	181.3M
Property Plant And Equipment Gross	11.9M	11.3M	16.9M	20.1M	20.4M	21.4M
Long Term Debt	12.2M	12.4M	71.7M	104.2M	183.2M	192.3M
Net Tangible Assets	25.0M	24.9M	(6.2M)	1.4M	1.6M	1.6M
Current Deferred Revenue	57K	66K	16K	113K	75K	71.3K
Retained Earnings Total Equity	(74.0M)	(77.4M)	(95.4M)	(109.5M)	(98.5M)	(103.5M)
Capital Surpluse	101.7M	104.6M	106.7M	137.1M	157.6M	85.0M
Short Term Debt	2.4M	5.1M	560K	723K	806K	765.7K
Non Currrent Assets Other	7.7M	3.8M	12.4M	2.0M	(2.1M)	(2.0M)
Accumulated Other Comprehensive Income	(2.8M)	(4.4M)	0.0	(409K)	(368.1K)	(386.5K)
Property Plant Equipment	5.4M	4.5M	3.1M	3.5M	4.0M	3.9M
Short Term Investments	25.2M	28.5M	8.5M	5.6M	8.7M	9.9M
Net Receivables	2.7M	2.7M	4.5M	6.4M	36.5M	38.3M
Long Term Debt Total	12.2M	12.4M	71.7M	104.2M	119.8M	125.8M
Capital Lease Obligations	7M	7.3M	6.3M	8.1M	7.3M	4.3M
Inventory	3.3M	4.0M	4.2M	6.5M	10.9M	11.4M
Non Current Liabilities Other	7.2M	7.5M	6.0M	7.3M	8.4M	8.9M
Intangible Assets	2.3M	1.9M	17.1M	25.8M	162.0M	170.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Harrow Stock Analysis

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Harrow Selling And Marketing Expenses vs Total Revenue Analysis

Selling And Marketing Expenses vs Total Revenue

Selling And Marketing Expenses vs Total Revenue Correlation Analysis

Correlation Coefficient

Selling And Marketing Expenses

Total Revenue

Harrow Health fundamental ratios Correlations

Harrow Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Harrow Health fundamental ratios Accounts

Also Currently Popular

Additional Tools for Harrow Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Short Long Term Debt Total	+ 1.0	Total Liab
Non Current Liabilities Total	+ 1.0	Total Liab
Long Term Debt	+ 1.0	Total Liab
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Short Long Term Debt Total

Other Stockholder Equity	- 0.96	Retained Earnings
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Retained Earnings Total Equity	- 0.93	Common Stock Shares Outstanding
Property Plant And Equipment Gross	- 0.92	Retained Earnings
Common Stock Total Equity	- 0.92	Retained Earnings
Retained Earnings Total Equity	- 0.91	Property Plant And Equipment Gross